Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL96736

O.O=C(O)C(F)(F)F

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO

The experimentally established mechanism targets of Trifluoroacetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2060 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-224251105-U Magnetic attraction type tea-water separation teacup 上海庶钿家居用品有限公司 2026-05-19 CN claimed
CN-122010766-A Cyclohexene derivative, preparation method and application thereof 浙江海洋大学 2026-05-12 CN claimed
EP-4731545-A2 CAPSULE OR CAPSULE STRUCTURE, PREPARATION DEVICE FOR PREPARING A COFFEE BEVERAGE OR TEA BEVERAGE USING A CAPSULE OR CAPSULE STRUCTURE, AND METHOD FOR PREPARING A COFFEE BEVERAGE OR TEA BEVERAGE Eriver AG (CH) 2026-04-29 EP claimed
CN-222885288-U Magnetic tea water separation cup 佛山市南海区罗村金丰电器配件厂 2025-05-20 CN claimed
CN-222870210-U Antiskid and heat-insulating tea-water separation type glass cup 安徽圣洁家居有限公司 2025-05-16 CN claimed
CN-116242938-B Determination method of sodium stearyl fumarate impurity 北京吉洛华制药有限公司 2025-05-13 CN claimed
CN-119643734-A Detection method of poloxamer 188 in polyethylene glycol human erythropoietin 华润昂德生物药业有限公司 2025-03-18 CN claimed
CN-119574736-A Method for detecting content of free PEG in polyethylene glycol human erythropoietin 华润昂德生物药业有限公司 2025-03-07 CN claimed
CN-222382959-U Rotatory upset magnetism is inhaled tea water and is separated cup 安徽省富光实业股份有限公司 2025-01-24 CN claimed
CN-119335099-A Synchronous detection method for impurities contained in candesartan cilexetil and amlodipine besylate 福安药业集团庆余堂制药有限公司 2025-01-21 CN claimed
EP-1931693-A2 PROCESS FOR PREPARING GEMCITABINE AND ASSOCIATED INTERMEDIATES CHEMAGIS LTD. (IL) 2008-06-18 EP claimed
CN-101028320-A Vegetable medicinal composition with hypoglycemic and hypolipidemic functions and its making method JIADEEN MEDICAL CO LTD GUANGZH (CN) 2007-09-05 CN claimed
CN-1326858-C tricyclic spiropiperidine compounds ASTRAZENECA AB (SE) 2007-07-18 CN claimed
CN-1320104-C Bacterial strain for preparing high efficiency capsule glycoprotein immunomodulator, screening and application thereof UNIV TIANJIN MEDICAL (CN) 2007-06-06 CN claimed
WO-2007027564-A2 PROCESS FOR PREPARING GEMCITABINE AND ASSOCIATED INTERMEDIATES CHEMAGIS LTD. (IL) 2007-03-08 WO claimed
EP-1607400-A2 Salts of dialkylphosphinic acids, process for their preparation and their use Clariant GmbH (DE) 2005-12-21 EP claimed
CN-1675218-A Novel tricyclic spiropiperidines or spiropyrrolidines ASTRAZENECA AB (SE) 2005-09-28 CN claimed
CN-1524950-A Bacterial strain for preparing high efficiency capsule glycoprotein immunomodulator, screening and application thereof 天津医科大学 2004-09-01 CN claimed
US-6025507-A Borneol derivatives, methods of manufacturing them, and their pharmaceutical use SCHERING AKTIENGESELLSCHAFT (DE) 2000-02-15 US claimed
EP-0378318-A1 Process for synthesis of FK-506 and tricarbonyl intermediates MERCK & CO. INC. (US) 1990-07-18 EP claimed